Navigation Links
Strides Made in Hemophilia Research
Date:6/16/2009

Successful blood-clotting in lab could pave way for human trials, researchers say

TUESDAY, June 16 (HealthDay News) -- Researchers studying the bleeding disease hemophilia in mice have increased the rodents' ability to produce a crucial blood-clotting protein, a new study says. Their success may pave the way for human trials.

Past studies have successfully introduced a gene into animals' cells to make the clotting protein, Factor VIII, which is missing in people with hemophilia. But attempts at gene therapy in humans have been disappointing, the study authors note.

In the new study, the researchers say they have developed an approach to target genes in mouse liver sinusoidal endothelial cells, which are the main source of Factor VIII.

Researchers hope the new approach will be a step toward successful human clinical trials in individuals with hemophilia A, the most common form of the inherited disorder.

The study by researchers from the University of Minnesota Medical School in Minneapolis is in the June issue of the Journal of Clinical Investigation.

In the study, researchers used nanoparticles coated with hyaluron to target liver sinusoidal endothelial cells. The nanoparticles contained a therapeutic gene (Factor VIII) as well as Sleeping Beauty, a genetic element that helps the therapeutic gene become inserted into the genome of the targeted cells.

Fifty weeks after the treatment, mice injected with these nanoparticles had Factor VIII levels that were the same as those of normal mice. Bleeding times were also similar to those of normal mice.

According to a news release from the journal, it is the authors hope that the combination of Sleeping Beauty and the cell-specific nanocapsule delivery system will result in a successful gene therapy.

More information

The National Heart, Lung and Blood Institute has more on hemophilia.



-- Jennifer Thomas



SOURCE: Journal of Clinical Investigation, news release, June 8, 2009


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Twenty-Five Individuals Honored by Yoplait(R) for Making Extraordinary Strides in the Fight Against Breast Cancer
2. GREAT STRIDES Walks for Cystic Fibrosis Slated for 47 States This Weekend
3. Gentiva Safe Strides(R) Home Balance Therapy Program is Reducing Risk of Dangerous Falls and Relieving Pain for Thousands of Older Americans
4. Stroller Strides(R) Franchises Succeed Despite Economic Climate
5. Stroller Strides(R) Signs Pampers(R) as Premier Sponsor for 2009
6. Womans Day Presents the Sixth Annual Red Dress Awards Honoring Women Making Strides in the Fight Against Heart Disease
7. Cystic Fibrosis Foundation Launches GREAT STRIDES Walks Nationwide at 600 Locations
8. Nektar Announces Agreement With Baxter to Develop New PEGylated Therapeutics for Hemophilia
9. Transplanted Liver Lining Cells May Cure Hemophilia
10. Wyeths XYNTHA Approved by FDA for Treatment of Hemophilia A
11. eWorld Companies, Inc. Establishes Strategic Alliance With Hemophilia Foundation of Southern California
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Strides Made in Hemophilia Research
(Date:2/6/2016)... ... February 06, 2016 , ... FOR INFORMATION: ... AORN SURGICAL CONFERENCE & EXPO , WHAT:     , This conference is the ... perioperative nurses in attendance to study the latest evidence-based recommendations and resources ...
(Date:2/6/2016)... ... February 06, 2016 , ... Research has shown ... to reduce the frequency and level of relapse. , At the ... and Purpose,” will explore the critical tasks of the recovery phase and beyond ...
(Date:2/5/2016)... , ... February 05, 2016 , ... Today, the Whole-Food ... announced that the much-anticipated feature with author Jahnavi Foster, specialist in healthy vegetarian cuisine, ... Network. , Each week, on his weekly Whole-Food Warrior TV show, Frank Davis highlights ...
(Date:2/5/2016)... (PRWEB) , ... February 05, 2016 , ... ... announce the addition of micro-needling services in their Napa Valley office. The technique ... of Plastic Surgery Associates, Dr. Canales and Dr. Furnas, are part of only ...
(Date:2/5/2016)... ... February 05, 2016 , ... The ... funding innovative lymphoma research and serving the lymphoma community through a comprehensive series ... again host, Swirl, A Wine Tasting Event at the La Gorce Country Club ...
Breaking Medicine News(10 mins):
(Date:2/5/2016)... SAN DIEGO , Feb. 5, 2016 Aethlon ... Jim Joyce , Chairman and CEO, will be presenting at ... New York, NY at 2:15 p.m. ... participate in an Immunotherapy Panel discussion taking place at 3:15 ... available for replay approximately one hour after the conclusion of ...
(Date:2/5/2016)... February 5, 2016 --> ... report states that the global active pharmaceuticals ingredients (APIs) ... predicted to reach US$185.9 bn by 2020. It is ... 2014 to 2020. The title of the report is ... by Geography, and by Therapeutic Area) - Global Industry ...
(Date:2/5/2016)... 5, 2016  Zimmer Biomet Holdings, Inc. (NYSE and ... announced underwritten secondary offering of 11,027,558 shares of its ... affiliates of Blackstone and Goldman Sachs.  The shares are ... of $96.45 per share. The selling stockholders will receive ... Biomet nor any of its directors, officers or other ...
Breaking Medicine Technology: